Sipuleucel-T in African Americans: A subgroup analysis of three phase III sipuleucel-T trials in advanced prostate cancer.

被引：8
|
作者：
McLeod, D. G.
Quinn, D. I.
Whitmore, J. B.
Tabesh, M.
机构：
[1] Walter Reed Army Med Ctr, Washington, DC 20307 USA
[2] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA
[3] Dendreon Corp, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15148
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SIPULEUCEL-T IN AFRICAN AMERICANS: A SUBGROUP ANALYSIS OF THREE PHASE 3 TRIALS OF SIPULEUCEL-T IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER
    McLeod, David G.
    Quinn, David I.
    Cullen, Jennifer
    Whitmore, James B.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E388 - E388
  • [2] Sipuleucel-T: immunotherapy for advanced prostate cancer
    Olson, Brian M.
    McNeel, Douglas G.
    [J]. RESEARCH AND REPORTS IN UROLOGY, 2011, 3 : 49 - 60
  • [3] Sipuleucel-T for the Treatment of Advanced Prostate Cancer
    Frohlich, Mark W.
    [J]. SEMINARS IN ONCOLOGY, 2012, 39 (03) : 245 - 252
  • [4] Sipuleucel-T for the treatment of prostate cancer
    Harzstark, Andrea L.
    Small, Eric J.
    [J]. DRUGS OF TODAY, 2008, 44 (04) : 271 - 278
  • [5] Phase III trial of sipuleucel-T
    不详
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 202 - 202
  • [6] Sipuleucel-T and immunotherapy in the treatment of prostate cancer
    Dawson, Nancy A.
    Roesch, Erin E.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (05) : 709 - 719
  • [7] Antigen spread and survival with sipuleucel-T in patients with advanced prostate cancer.
    Drake, Charles G.
    Fan, Li-Qun
    GuhaThakurta, Debraj
    Stewart, Frances
    Kantoff, Philip W.
    Small, Eric Jay
    Gardner, Thomas A.
    Sheikh, Nadeem A.
    Trager, James B.
    Higano, Celestia S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [8] Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
    Kantoff, Philip W.
    Higano, Celestia S.
    Shore, Neal D.
    Berger, E. Roy
    Small, Eric J.
    Penson, David F.
    Redfern, Charles H.
    Ferrari, Anna C.
    Dreicer, Robert
    Sims, Robert B.
    Xu, Yi
    Frohlich, Mark W.
    Schellhammer, Paul F.
    Ahmed, T.
    Amin, A.
    Arseneau, J.
    Barth, N.
    Bernstein, G.
    Bracken, B.
    Burch, P.
    Caggiano, V.
    Chin, J.
    Chodak, G.
    Chu, F.
    Corman, J.
    Curti, B.
    Dawson, N.
    Deeken, J. F.
    Dubernet, T.
    Fishman, M.
    Flanigan, R.
    Gailani, F.
    Garbo, L.
    Gardner, T.
    Gelmann, E.
    George, D.
    Godfrey, T.
    Gomella, L.
    Guerra, M.
    Hall, S.
    Hanson, J.
    Israeli, R.
    Jancis, E.
    Jewett, M. A. S.
    Kassabian, V.
    Katz, J.
    Klotz, L.
    Koeneman, K.
    Koh, H.
    Kratzke, R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05): : 411 - 422
  • [9] Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T
    Quinn, David I.
    Vaishampayan, Ulka
    Higano, Celestia S.
    Lin, Daniel W.
    Shore, Neal D.
    Beer, Tomasz M.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (01) : 51 - 61
  • [10] Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?
    Bitting, Rhonda L.
    Armstrong, Andrew J.
    George, Daniel J.
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 325 - 332
12345